Probiotec Ltd
ASX:PBP

Watchlist Manager
Probiotec Ltd Logo
Probiotec Ltd
ASX:PBP
Watchlist
Price: 3.03 AUD 0.66% Market Closed
Updated: May 31, 2024

Probiotec Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Probiotec Ltd
Revenue Peer Comparison

Comparables:
MYX
NEU
BOT
C
CU6
VLS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Probiotec Ltd
ASX:PBP
Revenue
AU$221.2m
CAGR 3-Years
28%
CAGR 5-Years
24%
CAGR 10-Years
13%
Mayne Pharma Group Ltd
ASX:MYX
Revenue
AU$190.3m
CAGR 3-Years
-25%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Revenue
AU$237.6m
CAGR 3-Years
550%
CAGR 5-Years
77%
CAGR 10-Years
47%
Botanix Pharmaceuticals Ltd
ASX:BOT
Revenue
AU$588.4k
CAGR 3-Years
56%
CAGR 5-Years
26%
CAGR 10-Years
N/A
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Revenue
AU$11.7m
CAGR 3-Years
59%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vita Life Sciences Ltd
ASX:VLS
Revenue
AU$74.2m
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
8%

See Also

What is Probiotec Ltd's Revenue?
Revenue
221.2m AUD

Based on the financial report for Dec 31, 2023, Probiotec Ltd's Revenue amounts to 221.2m AUD.

What is Probiotec Ltd's Revenue growth rate?
Revenue CAGR 10Y
13%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Probiotec Ltd have been 28% over the past three years , 24% over the past five years , and 13% over the past ten years .